| |
|
Period 1 |
Period 2 |
| |
n |
Conc(ng/mL) |
log conc |
Conc(ng/mL) |
log conc |
| Hemolyzed sample |
16 |
1322.87 ± 392.96 |
3.11 ± 0.12 |
1146.30 ± 249.89 |
3.05 ± 0.10 |
| Non-hemolyzed sample |
16 |
1151.42 ± 299.91 |
3.05 ± 0.11 |
1220.01 ± 196.67 |
3.07 ± 0.11 |
| t |
|
1.387 |
1.436 |
0.7602 |
0.6609 |
| P |
|
0.1756 |
0.1614 |
0.4531 |
0.5137 |
|
| Ropinirole plasma concentration at 4 hour post dosing during the first period and
second period Ropinirole pilot BE study |
| Table 2: Ropinirole Concentrations (ng/mL). |
